17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?

被引:0
|
作者
Hynes, Jenna S. [1 ]
Schwartz, Amanda R. [1 ]
Abdalla, Azza [1 ]
Manuck, Tracy A. [2 ]
Dotters-Katz, Sarah K. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, 201 Trent Dr, Durham, NC 27710 USA
[2] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC USA
关键词
D O I
10.1016/j.ajogmf.2020.100278
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Uterine Activity in Women Receiving 17 α-Hydroxyprogesterone Caproate for the Prevention of Preterm Birth: An Observational Study
    O'Brien, John M.
    Ho, Shannon J.
    Istwan, Niki B.
    Stanziano, Gary J.
    Rhea, Debbie J.
    Barton, John R.
    AMERICAN JOURNAL OF PERINATOLOGY, 2010, 27 (02) : 157 - 162
  • [22] Impact of Obesity on the Rate of Recurrent Spontaneous Preterm Birth in Women Treated with 17-alpha Hydroxyprogesterone Caproate
    Hauspurg, Alisse
    Lemon, Lara S.
    Serra, Allison E.
    Sharma, Shringi
    Venkataramanan, Raman
    Caritis, Steve N.
    AMERICAN JOURNAL OF PERINATOLOGY, 2018, 35 (09) : 809 - 814
  • [23] Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial
    Boelig, Rupsa C.
    Schoen, Corina N.
    Frey, Heather
    Gimovsky, Alexis C.
    Springel, Edward
    Backley, Sami
    Berghella, Vincenzo
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (05)
  • [24] Use of 17-Hydroxyprogesterone Caproate in Twin Gestations With a Prior Singleton Spontaneous Preterm Birth
    Ward, Andrew R.
    Greenberg, Victoria Rachel
    Valcarcel, Breanna
    Al-Kouatly, Huda Bachir
    Berghella, Vincenzo
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 221S - 221S
  • [25] Rates of recurrent preterm birth by maternal body habitus in women receiving 17α-hydroxyprogesterone caproate
    Timofeev, Julia
    Feghali, Maisa
    Boyle, Annelee
    Istwan, Niki
    Rhea, Debbie
    Driggers, Rita W.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2013, 26 (09): : 881 - 884
  • [26] Recurrent spontaneous preterm birth risk is not associated with 17-alpha hydroxyprogesterone caproate levels
    Downes, Katheryne L.
    Venkataramanan, Raman
    Caritis, Steve
    Elovitz, Michal A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S422 - S423
  • [27] Prevention of preterm delivery with 17-hydroxyprogesterone caproate: Pharmacologic considerations
    Feghali, Maisa
    Venkataramanan, Raman
    Caritis, Steve
    SEMINARS IN PERINATOLOGY, 2014, 38 (08) : 516 - 522
  • [28] A randomized controlled trial of 17-hydroxyprogesterone caproate (17-DHPC) for the prevention of preterm birth in twins
    Caritis, Steve
    Rouse, Dwight
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : S2 - S2
  • [29] Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention
    Manuck, Tracy A.
    Watkins, W. Scott
    Moore, Barry
    Esplin, M. Sean
    Varner, Michael W.
    Jackson, G. Marc
    Yandell, Mark
    Jorde, Lynn
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (04) : 321.e1 - 321.e21
  • [30] Effect of obesity on efficacy of 17 hydroxyprogesterone caproate in preventing recurrent preterm birth
    Stout, Molly J.
    Odibo, Anthony O.
    Macones, George A.
    Cahill, Alison G.
    Fowler, Susan A.
    Tuuli, Methodius G.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (01) : S348 - S349